NAUT

Nautilus Biotechnology INC

+$97.4M

Net Activity

Institutions Holding

83

Popularity Rank

#4868

Avg Weight

0.12%

Total Value

$211.0M

Ownership Trend

83 institutions currently hold NAUT, with 40 net buyers and 24 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

24

Net Buying Institutions

40

Key Holders

View all 83 holding institutions

Quarterly Activity

Recent Activity

+$29.1M

Total Buy Value

$2.5M

Total Sell Value

New buy23
Trim16
Add17
Sold out8

40

Net Buyers

24

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

1

Active 5%+ Holders

Data as of 2026-06-30
Reporting PersonTypeFiling Date% of Class
AH Bio Fund II, L.P.13D/A2026-06-307.1%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NAUTILUS BIOTECHNOLOGY INC (NAUT)?
Major stakeholders currently include a16z Capital Management, L.L.C. ($68.5M), Perceptive Advisors LLC ($48.9M), Cercano Management LLC ($27.8M). Based on the latest 13F filings, there are a total of 83 tracked investment funds and institutions maintaining positions in NAUT.
What is the overall institutional sentiment toward NAUT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $97.4M, driven by 40 managers accumulating shares while 24 reduced their exposure.
Which institutions have been selling or reducing their NAUT positions?
In the latest period, 16 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $2.5M.
Are there any notable investors adding NAUT to their portfolios?
Yes, buying activity remains notable. 23 institutions opened new positions in {ticker}, and 17 existing holders added to their shares. The total reported buy value for the quarter amounted to $29.1M.

Related Stocks